LONDON, Feb 21 (Reuters) - European regulators said onFriday they had recommended approval of 10 drugs, six of whichwere for respiratory diseases including GlaxoSmithKline's Anoro and Laventair and Novartis's UlunarBreezhaler.
The European Medicine Agency (EMA) also gave the green lightto Vokanamet, a treatment for type 2 diabetes marketed byJohnson & Johnson.
Recommendations for marketing approval by the EMA'sCommittee for Medicinal Products for Human Use (CHMP) arenormally endorsed by the European Commission within a couple ofmonths.
Glaxosmithkline (GSK)
